Tokyo, Oct. 23 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063366) titled 'Collection and storage of residual tissue, blood, and clinical information from patients with liver cancer for future research' on Oct. 22.

Study Type: Observational

Primary Sponsor: Institute - Sapporo Medical University School of Medicine

Condition: Condition - Hepatocellular carcinoma Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - To establish a biobank and database for research on the pathogenesis of liver diseases and for the discovery of diagnostic, prognostic, and predictive biomarkers. The biobank will collect and store residual tissue (tumor and non-tumor) obtained during routine clinical care of patients with hepatocellular carcinoma, peripheral blood collected for research purposes, and associated clinical information. This study is limited to collecting and storing specimens and data; each analytical study using them will be conducted under a separate protocol approved by the ethics committee. Basic objectives2 - Others

Eligibility: Age-lower limit - 20 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Patients who meet all of the following criteria: Patients diagnosed with hepatocellular carcinoma who undergo treatment (surgery, biopsy, puncture, catheter-based therapy, etc.) at Sapporo Medical University Hospital Patients aged 20 years or older at the time of consent Patients who have given written informed consent to participate in this study Patients from whom residual tissue is obtained during clinical care, or from whom blood can be collected for research purposes Key exclusion criteria - Patients who meet any of the following criteria: Patients who do not consent to participate in this study Patients for whom blood collection or specimen sampling for research is judged difficult by the investigators, for example because of poor general condition Patients otherwise judged by the investigators to be unsuitable for this study Target Size - 90

Recruitment Status: Recruitment status - Enrolling by invitation Date of protocol fixation - 2026 Year 08 Month 24 Day Date of IRB - 2026 Year 10 Month 18 Day Anticipated trial start date - 2026 Year 10 Month 22 Day Last follow-up date - 2031 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072533

Disclaimer: Curated by HT Syndication.